PRECISESADS General Assembly

• IMI
• European Union
• EFPIA

This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.

PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.